Advertisement

Cell and Tissue Research

, Volume 375, Issue 2, pp 397–408 | Cite as

Enrichment of cancer stem cells by agarose multi-well dishes and 3D spheroid culture

  • Xiaoling Guo
  • Yong Chen
  • Weiping Ji
  • Xianwu Chen
  • Chao Li
  • Renshan GeEmail author
Regular Article

Abstract

As the theory of cancer stem cells (CSCs) is maturing, CSC-targeted therapy is emerging as an important therapeutic strategy and seeking the ideal method for rapid enrichment and purification of CSCs has become crucial. So far, based on the known CSC phenotypes and biological characteristics, the methods for enrichment CSCs mainly include low adhesion culture, low oxygen culture, chemotherapy drug stimulation and side population (SP) sorting but these methods cannot realize quick enrichment of the desired CSCs. Herein, we adopt a novel method that efficiently enriches a certain amount of CSCs through agarose multi-well dishes using rubber micro-molds to make cancer cells into cell spheroids (3D). These 3D cancer cell spheroids in the proportions of expression of CSC biomarkers (single stain of CD44, CD44v6 and CD133 or double stain of both CD44 and CD133) were significantly higher than those of the conventional adherent culture (2D) using flow cytometry analysis. In addition, the expression levels of stemness transcription factors such as OCT4, NANOG and SOX2 in 3D were also significantly higher than that in 2D through Western blot (WB) and quantitative polymerase chain reaction (qPCR) assays. In addition, the CSCs in 3D could form colonies with different sizes in soft agar. In conclusion, we developed a new method to enrich some kinds of CSCs, which might be a benefit for future CSC-targeted therapy studies and anti-CSC drug screening applications.

Keywords

Cancer stem cell 2D 3D Spheroid Enrichment 

Notes

Funding

This work was supported by the National Nature Science Foundation of China (81701426, 81730042 and 81771636), the Medical and Health Research Science and Technology Plan Project of Zhejiang Province (2018KY523, 2017KY473 and 2017ZB067) and the Public Welfare Science and Technology Plan Project of Wenzhou City (Y20170151, Y20160069 and ZS2017012).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983–3988CrossRefGoogle Scholar
  2. Bhaskara VK, Mohanam I, Rao JS, Mohanam S (2012) Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells. PLoS One 7:e30905CrossRefGoogle Scholar
  3. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737CrossRefGoogle Scholar
  4. Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z (2011) Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 11:71CrossRefGoogle Scholar
  5. Chien CY, Chuang HC, Chen CH (2012) The side population of cancer stem-like cells in human oral cancer. Oral Oncol 48:913–914CrossRefGoogle Scholar
  6. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339–9344CrossRefGoogle Scholar
  7. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946–10951CrossRefGoogle Scholar
  8. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, Chen Q (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res : Off J Am Assoc Cancer Res 14:6751–6760CrossRefGoogle Scholar
  9. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y (2009) Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 34:1381–1386Google Scholar
  10. Garcion E, Halilagic A, Faissner A, ffrench-Constant C (2004) Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131:3423–3432CrossRefGoogle Scholar
  11. Gou S, Liu T, Wang C, Yin T, Li K, Yang M, Zhou J (2007) Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas 34:429–435CrossRefGoogle Scholar
  12. Guo X, Li S, Ji Q, Lian R, Chen J (2015a) Enhanced viability and neural differential potential in poor post-thaw hADSCs by agarose multi-well dishes and spheroid culture. Hum Cell 28:175–189CrossRefGoogle Scholar
  13. Guo X, Lian R, Guo Y, Liu Q, Ji Q, Chen J (2015b) bFGF and Activin A function to promote survival and proliferation of single iPS cells in conditioned half-exchange mTeSR1 medium. Hum Cell 28:122–132CrossRefGoogle Scholar
  14. Guo Y, Liu Q, Yang Y, Guo X, Lian R, Li S, Wang C, Zhang S, Chen J (2015c) The effects of ROCK inhibitor Y-27632 on injectable spheroids of bovine corneal endothelial cells. Cell Reprogram 17:77–87CrossRefGoogle Scholar
  15. Heider KH, Kuthan H, Stehle G, Munzert G (2004) CD44v6: a target for antibody-based cancer therapy. Cancer Immunol, Immunother: CII 53:567–579Google Scholar
  16. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323CrossRefGoogle Scholar
  17. Hu X, Ghisolfi L, Keates AC, Zhang J, Xiang S, Lee DK, Li CJ (2012) Induction of cancer cell stemness by chemotherapy. Cell Cycle 11:2691–2698CrossRefGoogle Scholar
  18. Huang YC, Chan CC, Lin WT, Chiu HY, Tsai RY, Tsai TH, Chan JY, Lin SJ (2013) Scalable production of controllable dermal papilla spheroids on PVA surfaces and the effects of spheroid size on hair follicle regeneration. Biomaterials 34:442–451CrossRefGoogle Scholar
  19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefGoogle Scholar
  20. Jin X, Jin X, Kim H (2017) Cancer stem cells and differentiation therapy. Tumour Biol: J Int Socr Oncodev Biol Med 39:1010428317729933Google Scholar
  21. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Scholer HR (2009) Oct4-induced pluripotency in adult neural stem cells. Cell 136:411–419CrossRefGoogle Scholar
  22. Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W (2012) Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer 130:29–39CrossRefGoogle Scholar
  23. Lee MK, Lin SP, HuangFu WC, Yang DS, Liu IH (2017a) Endothelial-derived extracellular matrix ameliorate the stemness deprivation during ex vivo expansion of mouse bone marrow-derived mesenchymal stem cells. PLoS One 12:e0184111CrossRefGoogle Scholar
  24. Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS (2017b) Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 16:10CrossRefGoogle Scholar
  25. Li C, Lee CJ, Simeone DM (2009) Identification of human pancreatic cancer stem cells. Methods Mol Biol 568:161–173CrossRefGoogle Scholar
  26. Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A (2012) Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 12:48CrossRefGoogle Scholar
  27. Meirelles K, Benedict LA, Dombkowski D, Pepin D, Preffer FI, Teixeira J, Tanwar PS, Young RH, MacLaughlin DT, Donahoe PK, Wei X (2012) Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance. Proc Natl Acad Sci U S A 109:2358–2363CrossRefGoogle Scholar
  28. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106–110CrossRefGoogle Scholar
  29. Orian-Rousseau V (2010) CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46:1271–1277CrossRefGoogle Scholar
  30. Page H, Flood P, Reynaud EG (2013) Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res 352:123–131CrossRefGoogle Scholar
  31. Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A (2017) Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol 44:10–24CrossRefGoogle Scholar
  32. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65:5506–5511CrossRefGoogle Scholar
  33. Rao Pattabhi S, Martinez JS, Keller TC 3rd (2014) Decellularized ECM effects on human mesenchymal stem cell stemness and differentiation. Differentiation 88:131–143Google Scholar
  34. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111–115Google Scholar
  35. Salmanzadeh A, Romero L, Shafiee H, Gallo-Villanueva RC, Stremler MA, Cramer SD, Davalos RV (2012) Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature. Lab Chip 12:182–189CrossRefGoogle Scholar
  36. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH (2008) Identification of cells initiating human melanomas. Nature 451:345–349CrossRefGoogle Scholar
  37. Sell S (2004) Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51:1–28CrossRefGoogle Scholar
  38. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828Google Scholar
  39. Song X, Zhu CH, Doan C, Xie T (2002) Germline stem cells anchored by adherens junctions in the Drosophila ovary niches. Science 296:1855–1857CrossRefGoogle Scholar
  40. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27:1006–1020CrossRefGoogle Scholar
  41. Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S, Cocorullo G, Gulotta G, Dieli F, De Maria R, Stassi G (2014) CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 14:342–356CrossRefGoogle Scholar
  42. Velasco-Velazquez MA, Homsi N, De La Fuente M, Pestell RG (2012) Breast cancer stem cells. Int J Biochem Cell Biol 44:573–577CrossRefGoogle Scholar
  43. Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC (2012) ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Am J Pathol 180:1159–1169CrossRefGoogle Scholar
  44. Wang D, Plukker JTM, Coppes RP (2017) Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer. Semin Cancer Biol 44:60–66CrossRefGoogle Scholar
  45. Xiong Y, He J, Zhang W, Zhou G, Cao Y, Liu W (2015) Retention of the stemness of mouse adipose-derived stem cells by their expansion on human bone marrow stromal cell-derived extracellular matrix. Tissue Eng A 21:1886–1894CrossRefGoogle Scholar
  46. Xu XX, Liu C, Liu Y, Yang L, Li N, Guo X, Sun GW, Ma XJ (2014) Enrichment of cancer stem cell-like cells by culture in alginate gel beads. J Biotechnol 177:1–12CrossRefGoogle Scholar
  47. Zhang Y, Wang Z, Yu J, Shi J, Wang C, Fu W, Chen Z, Yang J (2012) Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Cancer Lett 322:70–77CrossRefGoogle Scholar
  48. Zhang CL, Huang T, Wu BL, He WX, Liu D (2017) Stem cells in cancer therapy: opportunities and challenges. Oncotarget 8:75756–75766Google Scholar
  49. Zhang JC, Song ZC, Xia YR, Shu R (2018) Extracellular matrix derived from periodontal ligament cells maintains their stemness and enhances redifferentiation via the wnt pathway. J Biomed Mater Res A 106:272–284CrossRefGoogle Scholar
  50. Zhou G, Latchoumanin O, Bagdesar M, Hebbard L, Duan W, Liddle C, George J, Qiao L (2017) Aptamer-based therapeutic approaches to target cancer stem cells. Theranostics 7:3948–3961CrossRefGoogle Scholar
  51. Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J (2010) Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer 126:2067–2078CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Xiaoling Guo
    • 1
  • Yong Chen
    • 1
  • Weiping Ji
    • 2
  • Xianwu Chen
    • 1
  • Chao Li
    • 1
  • Renshan Ge
    • 1
    • 3
    Email author
  1. 1.Center of Scientific ResearchThe Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityWenzhouChina
  2. 2.Department of GastroenetrologyThe Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityWenzhouChina
  3. 3.Department of AnesthesiologyThe Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityWenzhouChina

Personalised recommendations